Review





Similar Products

enzyme linked immunosorbent assays  (Uman Diagnostics)
90
Uman Diagnostics enzyme linked immunosorbent assays
Enzyme Linked Immunosorbent Assays, supplied by Uman Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/enzyme linked immunosorbent assays/product/Uman Diagnostics
Average 90 stars, based on 1 article reviews
enzyme linked immunosorbent assays - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
enzyme linked immunosorbent assay elisa kits  (Elabscience Biotechnology)
95
Elabscience Biotechnology enzyme linked immunosorbent assay elisa kits
Enzyme Linked Immunosorbent Assay Elisa Kits, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/enzyme linked immunosorbent assay elisa kits/product/Elabscience Biotechnology
Average 95 stars, based on 1 article reviews
enzyme linked immunosorbent assay elisa kits - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier
rat specific enzyme linked immunosorbent assay elisa kits  (Sunlong Biotech Co Ltd)
86
Sunlong Biotech Co Ltd rat specific enzyme linked immunosorbent assay elisa kits
Rat Specific Enzyme Linked Immunosorbent Assay Elisa Kits, supplied by Sunlong Biotech Co Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat specific enzyme linked immunosorbent assay elisa kits/product/Sunlong Biotech Co Ltd
Average 86 stars, based on 1 article reviews
rat specific enzyme linked immunosorbent assay elisa kits - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
il 10 em0005 enzyme linked immunosorbent assay  (Huabio Inc)
86
Huabio Inc il 10 em0005 enzyme linked immunosorbent assay
Elevated plasma cfDNA levels in septic patients and associated transcriptomic changes. (A) Comparison of plasma cfDNA levels between healthy controls ( n = 26) and patients with sepsis ( n = 78). (B) Quantification of plasma cfDNA in healthy individuals and septic patients. (C—I) Spearman correlation analysis between plasma cfDNA levels and (C) ALT, (D) AST, (E) LDH, (F) IL-8, (G) <t>IL-10,</t> (H) SOFA score, and (I) APACHE II score in septic patients. (J) ROC curve evaluating the diagnostic performance of plasma cfDNA in distinguishing sepsis patients from healthy controls. (K) Whole-blood transcriptome sequencing cohort, comprising healthy controls ( n = 10) and septic patients ( n = 31). (L, M) Volcano plots showing differential gene expression identified using DESeq2 and edgeR, respectively. (N) Hierarchical clustering heatmap of overlapping dDEGs distinguishing septic patients from healthy controls. (O) GO enrichment analysis of DEGs highlighting biological processes related to autophagy, innate immune activation, and NF-κB signaling. (P) KEGG pathway enrichment analysis demonstrating significant enrichment of immune- and inflammation-associated pathways. (Q) GSEA showing activation of Toll-like receptor and NF-κB signaling pathways in septic patients. ****P < 0.0001.
Il 10 Em0005 Enzyme Linked Immunosorbent Assay, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/il 10 em0005 enzyme linked immunosorbent assay/product/Huabio Inc
Average 86 stars, based on 1 article reviews
il 10 em0005 enzyme linked immunosorbent assay - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
hev enzyme linked immunosorbent assay elisa kits  (Beijing Wantai Biological)
86
Beijing Wantai Biological hev enzyme linked immunosorbent assay elisa kits
Elevated plasma cfDNA levels in septic patients and associated transcriptomic changes. (A) Comparison of plasma cfDNA levels between healthy controls ( n = 26) and patients with sepsis ( n = 78). (B) Quantification of plasma cfDNA in healthy individuals and septic patients. (C—I) Spearman correlation analysis between plasma cfDNA levels and (C) ALT, (D) AST, (E) LDH, (F) IL-8, (G) <t>IL-10,</t> (H) SOFA score, and (I) APACHE II score in septic patients. (J) ROC curve evaluating the diagnostic performance of plasma cfDNA in distinguishing sepsis patients from healthy controls. (K) Whole-blood transcriptome sequencing cohort, comprising healthy controls ( n = 10) and septic patients ( n = 31). (L, M) Volcano plots showing differential gene expression identified using DESeq2 and edgeR, respectively. (N) Hierarchical clustering heatmap of overlapping dDEGs distinguishing septic patients from healthy controls. (O) GO enrichment analysis of DEGs highlighting biological processes related to autophagy, innate immune activation, and NF-κB signaling. (P) KEGG pathway enrichment analysis demonstrating significant enrichment of immune- and inflammation-associated pathways. (Q) GSEA showing activation of Toll-like receptor and NF-κB signaling pathways in septic patients. ****P < 0.0001.
Hev Enzyme Linked Immunosorbent Assay Elisa Kits, supplied by Beijing Wantai Biological, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hev enzyme linked immunosorbent assay elisa kits/product/Beijing Wantai Biological
Average 86 stars, based on 1 article reviews
hev enzyme linked immunosorbent assay elisa kits - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
enzyme linked immunosorbent assay elisa kits  (Siemens Healthineers)
86
Siemens Healthineers enzyme linked immunosorbent assay elisa kits
Elevated plasma cfDNA levels in septic patients and associated transcriptomic changes. (A) Comparison of plasma cfDNA levels between healthy controls ( n = 26) and patients with sepsis ( n = 78). (B) Quantification of plasma cfDNA in healthy individuals and septic patients. (C—I) Spearman correlation analysis between plasma cfDNA levels and (C) ALT, (D) AST, (E) LDH, (F) IL-8, (G) <t>IL-10,</t> (H) SOFA score, and (I) APACHE II score in septic patients. (J) ROC curve evaluating the diagnostic performance of plasma cfDNA in distinguishing sepsis patients from healthy controls. (K) Whole-blood transcriptome sequencing cohort, comprising healthy controls ( n = 10) and septic patients ( n = 31). (L, M) Volcano plots showing differential gene expression identified using DESeq2 and edgeR, respectively. (N) Hierarchical clustering heatmap of overlapping dDEGs distinguishing septic patients from healthy controls. (O) GO enrichment analysis of DEGs highlighting biological processes related to autophagy, innate immune activation, and NF-κB signaling. (P) KEGG pathway enrichment analysis demonstrating significant enrichment of immune- and inflammation-associated pathways. (Q) GSEA showing activation of Toll-like receptor and NF-κB signaling pathways in septic patients. ****P < 0.0001.
Enzyme Linked Immunosorbent Assay Elisa Kits, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/enzyme linked immunosorbent assay elisa kits/product/Siemens Healthineers
Average 86 stars, based on 1 article reviews
enzyme linked immunosorbent assay elisa kits - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
sandwich enzyme linked immunosorbent assay elisa assay  (Eurofins)
86
Eurofins sandwich enzyme linked immunosorbent assay elisa assay
Elevated plasma cfDNA levels in septic patients and associated transcriptomic changes. (A) Comparison of plasma cfDNA levels between healthy controls ( n = 26) and patients with sepsis ( n = 78). (B) Quantification of plasma cfDNA in healthy individuals and septic patients. (C—I) Spearman correlation analysis between plasma cfDNA levels and (C) ALT, (D) AST, (E) LDH, (F) IL-8, (G) <t>IL-10,</t> (H) SOFA score, and (I) APACHE II score in septic patients. (J) ROC curve evaluating the diagnostic performance of plasma cfDNA in distinguishing sepsis patients from healthy controls. (K) Whole-blood transcriptome sequencing cohort, comprising healthy controls ( n = 10) and septic patients ( n = 31). (L, M) Volcano plots showing differential gene expression identified using DESeq2 and edgeR, respectively. (N) Hierarchical clustering heatmap of overlapping dDEGs distinguishing septic patients from healthy controls. (O) GO enrichment analysis of DEGs highlighting biological processes related to autophagy, innate immune activation, and NF-κB signaling. (P) KEGG pathway enrichment analysis demonstrating significant enrichment of immune- and inflammation-associated pathways. (Q) GSEA showing activation of Toll-like receptor and NF-κB signaling pathways in septic patients. ****P < 0.0001.
Sandwich Enzyme Linked Immunosorbent Assay Elisa Assay, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sandwich enzyme linked immunosorbent assay elisa assay/product/Eurofins
Average 86 stars, based on 1 article reviews
sandwich enzyme linked immunosorbent assay elisa assay - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
variance bbs bardet biedl syndrome crs chronic rhinosinusitis elisa enzyme linked immunosorbent assay fda food  (Biotechnology Information)
86
Biotechnology Information variance bbs bardet biedl syndrome crs chronic rhinosinusitis elisa enzyme linked immunosorbent assay fda food
Elevated plasma cfDNA levels in septic patients and associated transcriptomic changes. (A) Comparison of plasma cfDNA levels between healthy controls ( n = 26) and patients with sepsis ( n = 78). (B) Quantification of plasma cfDNA in healthy individuals and septic patients. (C—I) Spearman correlation analysis between plasma cfDNA levels and (C) ALT, (D) AST, (E) LDH, (F) IL-8, (G) <t>IL-10,</t> (H) SOFA score, and (I) APACHE II score in septic patients. (J) ROC curve evaluating the diagnostic performance of plasma cfDNA in distinguishing sepsis patients from healthy controls. (K) Whole-blood transcriptome sequencing cohort, comprising healthy controls ( n = 10) and septic patients ( n = 31). (L, M) Volcano plots showing differential gene expression identified using DESeq2 and edgeR, respectively. (N) Hierarchical clustering heatmap of overlapping dDEGs distinguishing septic patients from healthy controls. (O) GO enrichment analysis of DEGs highlighting biological processes related to autophagy, innate immune activation, and NF-κB signaling. (P) KEGG pathway enrichment analysis demonstrating significant enrichment of immune- and inflammation-associated pathways. (Q) GSEA showing activation of Toll-like receptor and NF-κB signaling pathways in septic patients. ****P < 0.0001.
Variance Bbs Bardet Biedl Syndrome Crs Chronic Rhinosinusitis Elisa Enzyme Linked Immunosorbent Assay Fda Food, supplied by Biotechnology Information, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/variance bbs bardet biedl syndrome crs chronic rhinosinusitis elisa enzyme linked immunosorbent assay fda food/product/Biotechnology Information
Average 86 stars, based on 1 article reviews
variance bbs bardet biedl syndrome crs chronic rhinosinusitis elisa enzyme linked immunosorbent assay fda food - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier
enzyme linked immunosorbent assay elisa kit  (Cell Biolabs Inc)
86
Cell Biolabs Inc enzyme linked immunosorbent assay elisa kit
Elevated plasma cfDNA levels in septic patients and associated transcriptomic changes. (A) Comparison of plasma cfDNA levels between healthy controls ( n = 26) and patients with sepsis ( n = 78). (B) Quantification of plasma cfDNA in healthy individuals and septic patients. (C—I) Spearman correlation analysis between plasma cfDNA levels and (C) ALT, (D) AST, (E) LDH, (F) IL-8, (G) <t>IL-10,</t> (H) SOFA score, and (I) APACHE II score in septic patients. (J) ROC curve evaluating the diagnostic performance of plasma cfDNA in distinguishing sepsis patients from healthy controls. (K) Whole-blood transcriptome sequencing cohort, comprising healthy controls ( n = 10) and septic patients ( n = 31). (L, M) Volcano plots showing differential gene expression identified using DESeq2 and edgeR, respectively. (N) Hierarchical clustering heatmap of overlapping dDEGs distinguishing septic patients from healthy controls. (O) GO enrichment analysis of DEGs highlighting biological processes related to autophagy, innate immune activation, and NF-κB signaling. (P) KEGG pathway enrichment analysis demonstrating significant enrichment of immune- and inflammation-associated pathways. (Q) GSEA showing activation of Toll-like receptor and NF-κB signaling pathways in septic patients. ****P < 0.0001.
Enzyme Linked Immunosorbent Assay Elisa Kit, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/enzyme linked immunosorbent assay elisa kit/product/Cell Biolabs Inc
Average 86 stars, based on 1 article reviews
enzyme linked immunosorbent assay elisa kit - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

Image Search Results


Elevated plasma cfDNA levels in septic patients and associated transcriptomic changes. (A) Comparison of plasma cfDNA levels between healthy controls ( n = 26) and patients with sepsis ( n = 78). (B) Quantification of plasma cfDNA in healthy individuals and septic patients. (C—I) Spearman correlation analysis between plasma cfDNA levels and (C) ALT, (D) AST, (E) LDH, (F) IL-8, (G) IL-10, (H) SOFA score, and (I) APACHE II score in septic patients. (J) ROC curve evaluating the diagnostic performance of plasma cfDNA in distinguishing sepsis patients from healthy controls. (K) Whole-blood transcriptome sequencing cohort, comprising healthy controls ( n = 10) and septic patients ( n = 31). (L, M) Volcano plots showing differential gene expression identified using DESeq2 and edgeR, respectively. (N) Hierarchical clustering heatmap of overlapping dDEGs distinguishing septic patients from healthy controls. (O) GO enrichment analysis of DEGs highlighting biological processes related to autophagy, innate immune activation, and NF-κB signaling. (P) KEGG pathway enrichment analysis demonstrating significant enrichment of immune- and inflammation-associated pathways. (Q) GSEA showing activation of Toll-like receptor and NF-κB signaling pathways in septic patients. ****P < 0.0001.

Journal: International Journal of Pharmaceutics: X

Article Title: Engineered M2 macrophage-derived vesicles deliver DNase I for cfDNA clearance and multi-organ protection in sepsis

doi: 10.1016/j.ijpx.2026.100528

Figure Lengend Snippet: Elevated plasma cfDNA levels in septic patients and associated transcriptomic changes. (A) Comparison of plasma cfDNA levels between healthy controls ( n = 26) and patients with sepsis ( n = 78). (B) Quantification of plasma cfDNA in healthy individuals and septic patients. (C—I) Spearman correlation analysis between plasma cfDNA levels and (C) ALT, (D) AST, (E) LDH, (F) IL-8, (G) IL-10, (H) SOFA score, and (I) APACHE II score in septic patients. (J) ROC curve evaluating the diagnostic performance of plasma cfDNA in distinguishing sepsis patients from healthy controls. (K) Whole-blood transcriptome sequencing cohort, comprising healthy controls ( n = 10) and septic patients ( n = 31). (L, M) Volcano plots showing differential gene expression identified using DESeq2 and edgeR, respectively. (N) Hierarchical clustering heatmap of overlapping dDEGs distinguishing septic patients from healthy controls. (O) GO enrichment analysis of DEGs highlighting biological processes related to autophagy, innate immune activation, and NF-κB signaling. (P) KEGG pathway enrichment analysis demonstrating significant enrichment of immune- and inflammation-associated pathways. (Q) GSEA showing activation of Toll-like receptor and NF-κB signaling pathways in septic patients. ****P < 0.0001.

Article Snippet: Mouse tumor necrosis factor (TNF)-α (EM0010), interleukin (IL)-6 (EM0004), IL-1β (EM0029), and IL-10 (EM0005) enzyme-linked immunosorbent assay (ELISA) kits were obtained from HUABIO (Hangzhou, China).

Techniques: Clinical Proteomics, Comparison, Diagnostic Assay, Sequencing, Gene Expression, Activation Assay, Protein-Protein interactions

Therapeutic efficacy of M2-EVs@DNase I in septic mice. (A) Flow cytometry analysis of M1-phenotype macrophages (CD11b + F4/80 + CD86 + ) and M2-phenotype macrophages (CD11b + F4/80 + CD206 + ) in the peritoneal cavity. (B) Ratios of M2/M1 macrophages. (C, D) Flow cytometry and quantitative analysis of TLR9 + macrophages (CD11b + F4/80 + TLR9 + ). (E) The levels of cfDNA in the peritoneal fluid. (F—I) The concentrations of TNF-α, IL-1β, IL-6, and IL-10 in the peritoneal fluid. (J) Plasma cfDNA levels. (K-Q) Serum levels of PCT, CRP, SAA, TNF-α, IL-1β, IL-6, and IL-10 in each group. n = 3. Data are mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Journal: International Journal of Pharmaceutics: X

Article Title: Engineered M2 macrophage-derived vesicles deliver DNase I for cfDNA clearance and multi-organ protection in sepsis

doi: 10.1016/j.ijpx.2026.100528

Figure Lengend Snippet: Therapeutic efficacy of M2-EVs@DNase I in septic mice. (A) Flow cytometry analysis of M1-phenotype macrophages (CD11b + F4/80 + CD86 + ) and M2-phenotype macrophages (CD11b + F4/80 + CD206 + ) in the peritoneal cavity. (B) Ratios of M2/M1 macrophages. (C, D) Flow cytometry and quantitative analysis of TLR9 + macrophages (CD11b + F4/80 + TLR9 + ). (E) The levels of cfDNA in the peritoneal fluid. (F—I) The concentrations of TNF-α, IL-1β, IL-6, and IL-10 in the peritoneal fluid. (J) Plasma cfDNA levels. (K-Q) Serum levels of PCT, CRP, SAA, TNF-α, IL-1β, IL-6, and IL-10 in each group. n = 3. Data are mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001.

Article Snippet: Mouse tumor necrosis factor (TNF)-α (EM0010), interleukin (IL)-6 (EM0004), IL-1β (EM0029), and IL-10 (EM0005) enzyme-linked immunosorbent assay (ELISA) kits were obtained from HUABIO (Hangzhou, China).

Techniques: Drug discovery, Flow Cytometry, Clinical Proteomics